Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.616985
+0.0615 (11.07%)
At close: Jul 20, 2026, 4:00 PM EDT
0.5200
-0.0970 (-15.72%)
After-hours: Jul 20, 2026, 6:06 PM EDT
Barinthus Biotherapeutics Employees
Barinthus Biotherapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 91 or -86.67% compared to the previous year.
Employees
14
Change (1Y)
-91
Growth (1Y)
-86.67%
Revenue / Employee
n/a
Profits / Employee
-$3,736,500
Market Cap
25.20M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | -91 | -86.67% |
| Dec 31, 2024 | 105 | -25 | -19.23% |
| Dec 31, 2023 | 130 | 23 | 21.50% |
| Dec 31, 2022 | 107 | 35 | 48.61% |
| Dec 31, 2021 | 72 | 24 | 50.00% |
| Mar 31, 2021 | 49 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| NextCure | 40 |
| Jasper Therapeutics | 22 |
| NeuroSense Therapeutics | 17 |
| Quantum BioPharma | 17 |
| Atossa Therapeutics | 16 |
| NewcelX | 12 |
| Marker Therapeutics | 5 |
BRNS News
- 5 weeks ago - Barinthus Biotherapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Barinthus Biotherapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments - GlobeNewsWire
- 2 months ago - Barinthus Biotherapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Barinthus Biotherapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Barinthus Biotherapeutics Slides: Corporate presentation - Filings
- 4 months ago - Barinthus Biotherapeutics reports FY25 EPS ($1.64) vs ($1.55) last year - TheFly
- 4 months ago - Barinthus Biotherapeutics Earnings release: Q4 2025 - Filings